Last reviewed · How we verify

NCT05217394

Effectiveness of the Occupational Therapy Handwriting Intervention Guideline on Children

Completed NA Last updated 9 November 2022
What this trial tests

NA trial testing OTHIG in Difficulty Writing in 42 participants. Completed in 28 February 2022.

Timeline
1 October 2021
Primary endpoint
1 December 2021
28 February 2022

Quick facts

Lead sponsorNational University of Malaysia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment42
Start date1 October 2021
Primary completion1 December 2021
Estimated completion28 February 2022
Sites4 locations across Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

National University of Malaysia

Who can join

Adults 5 to 9, any sex, with Difficulty Writing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effectiveness of the Occupational Therapy Handwriting Interventions Guidelines (OTHIG) in enhancing handwriting performance among children. Method: Forty-two children recruited from private centers with occupational therapy indications and with handwriting issues, aged five to nine years, will be assigned to the experimental and control groups. Participants will receive a total of 10-week sessions, including training, intervention, and outcome measures. The experimental group will receive the developed OTHIG during handwriting skills intervention. Meanwhile, the control group will receive conventional interventions which not exposed to the OTHIG. This study is expected to provide evidence for the effectiveness of using the developed OTHIG to OTs in delivering their services, targeting children struggling with handwriting skills.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other National University of Malaysia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05217394.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing